FitLife Brands (FTLF) Benefited from MusclePharm Acquisition

Alluvial Capital Management, an investment advisory firm, has had a successful first quarter in 2024, as revealed in their recent investor letter. The Alluvial Fund saw a 6.3% increase in Q1, surpassing comparable indexes which only saw gains between 4.3% and 5.2%. This comprehensive growth was attributed to multiple assets in the portfolio making significant contributions.

One of the highlighted stocks in the investor letter was FitLife Brands, Inc. (NASDAQ:FTLF), a nutritional supplements provider based in Omaha, Nebraska. The stock closed at $27.95 per share on May 3, 2024, with a one-month return of 0.65% and a 62.03% increase in value over the last 52 weeks. FitLife Brands, Inc. has a market capitalization of $128.521 million.

Alluvial Capital Management praised FitLife Brands, Inc. in their investor letter, citing CEO Dayton Judd’s commentary on the MusclePharm acquisition during the company’s earnings call. The acquisition is expected to be financially beneficial, especially if previous best-selling products are reintroduced. One such product is the MusclePharm Combat Sport Bar, which previously sold 25 million units annually at its peak.

Despite its success, FitLife Brands, Inc. is not among the 30 Most Popular Stocks Among Hedge Funds. However, 2 hedge fund portfolios held the stock at the end of the fourth quarter. This news comes after River Oak Capital shared their views on the company in a previous article.

Investors and stakeholders can access more investor letters from hedge funds and leading investors on the Insider Monkey website. The positive performance of Alluvial Fund and its investments, particularly in FitLife Brands, Inc., showcase the firm’s strategic and successful investment approach in the first quarter of 2024.